Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Preferred Stock Liabilities (2020 - 2021)

Rapid Micro Biosystems' Preferred Stock Liabilities history spans 2 years, with the latest figure at $235.8 million for Q2 2021.

  • On a quarterly basis, Preferred Stock Liabilities rose 60.1% to $235.8 million in Q2 2021 year-over-year; TTM through Jun 2021 was $235.8 million, a 60.1% increase, with the full-year FY2020 number at $4.1 million, changed N/A from a year prior.
  • Preferred Stock Liabilities hit $235.8 million in Q2 2021 for Rapid Micro Biosystems, up from $233.8 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for RPID hit a ceiling of $235.8 million in Q2 2021 and a floor of $4.1 million in Q4 2020.